Stryker Corp., US8636671013

Stryker stock sits at EUR 245.40 with USD 105.5 billion market cap

Published on 10/08/2026 at 19:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stryker stock costs EUR 245.40 on October 8, 2026 after EUR 246.00, minus 0.24 percent. Its 52-week USD range is 267.00 to 392.55.

Key points in brief

  • Stryker stock was trading at EUR 245.40 at Lang & Schwarz on October 8, 2026, minus 0.24 percent versus EUR 246.00.
  • The stock's primary-market quote was USD 275.27 on the NYSE at 1:18 p.m. ET.
  • Stryker has a USD 105.5 billion market capitalization and a 28.51 P/E ratio.
  • Gekko lists October 29, 2026, after the close, as the next earnings date.
Makrofoto einer polierten Titan-Implantatoberfläche mit feiner Textur und Lichtreflexen
Makroaufnahme einer Titan-Implantatoberfläche zeigt Präzisionsfertigung, typisch für Produkte von Stryker Corp. US8636671013, Illustration mit AI erstellt.

Stryker Corp. (ISIN US8636671013) was trading at EUR 245.40 at Lang & Schwarz on October 8, 2026 at 7:08 p.m. CEST, minus 0.24 percent versus EUR 246.00. On the NYSE, Stryker last traded at USD 275.27 on October 8, 2026 at 1:18 p.m. ET, in the intraday session.

Price stays near yearly low

The Lang & Schwarz quote places the euro price EUR 21.60 below the USD 267.00 52-week low only as a nominal currency comparison, so the range is assessed in its original US-dollar quotation. The NYSE range runs from USD 267.00 to USD 392.55, while the latest primary-market quote was USD 275.27.

The stock's latest US-market quote was below its 50-day average of USD 306.83 and its 200-day average of USD 315.02, according to Gekko on October 8, 2026. That positioning makes the upcoming reporting date more important for the next market comparison.

Valuation and earnings date

Stryker's market capitalization was USD 105.5 billion on October 8, 2026, with a P/E ratio of 28.51. The company has a medical-device portfolio spanning orthopaedics, surgical equipment, patient care and neurotechnology, and its NYSE ticker is SYK, as listed by StockAnalysis.

Gekko lists October 29, 2026, after the close, as Stryker's next earnings date. Its analyst table also lists Barclays with a Buy rating and a USD 375.00 target dated October 7, 2026.

Comparison with peers

Stryker Corp.: minus 0.24 percent, P/E 28.51, market capitalization USD 105.5 billion
Medtronic (NYSE, USD): plus 3.32 percent, P/E 21.76, market capitalization USD 113.1 billion
Edwards Lifesciences (NYSE, USD): minus 2.65 percent, P/E 48.03, market capitalization USD 48.1 billion

After-hours euro quote

The Lang & Schwarz price was EUR 245.40 on October 8, 2026 at 7:08 p.m. CEST, minus 0.24 percent versus the EUR 246.00 prior close. The quote is in the after-hours phase from a German investor perspective.

The further course of trading is shown by the continuously updated real-time quote of Stryker stock.

Stryker stock market data

  • Company: Stryker Corporation
  • ISIN: US8636671013
  • Ticker: SYK
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 8, 2026, 7:08 p.m. CEST): EUR 245.40
  • Change versus prior close: minus 0.24 percent
  • Prior close Lang & Schwarz (October 7, 2026): EUR 246.00
  • Market capitalization: USD 105.5 billion (as of October 8, 2026)
  • 52-week range: USD 267.00-392.55 (as of October 8, 2026)
  • Sector / Industry: Healthcare / Medical Devices
  • Index membership: S&P 500
  • Next earnings date: October 29, 2026

Market context: Market report S&P 500.

More news and analyses on Stryker stock

Disclaimer...

en | US8636671013 | STRYKER CORP. | boerse | 70269397 | bgmi